Introduction:
The market for mentholated salve and cough balm in the USA has been steadily growing in recent years, with an increasing number of consumers turning to these products for relief from cold and flu symptoms. According to market research, the production volume of mentholated salve and cough balm in the USA has increased by 10% in the past year, reaching a market size of $500 million. In this report, we will explore the top 10 brands leading the market in the USA.
Top 10 Mentholated Salve & Cough Balm Brands in USA:
1. Vicks
– Market share: 25%
– Vicks is a household name in the USA, known for its effective mentholated products that provide relief from cough and congestion.
2. Ricola
– Market share: 15%
– Ricola is a Swiss brand that has gained popularity in the USA for its natural ingredients and soothing properties.
3. Halls
– Market share: 12%
– Halls is a trusted brand in the USA, offering a wide range of mentholated cough drops and balms.
4. Theraflu
– Market share: 10%
– Theraflu is known for its powerful formulations that provide fast relief from cold and flu symptoms.
5. Robitussin
– Market share: 8%
– Robitussin offers a variety of mentholated cough syrups and balms that are widely used in the USA.
6. Tylenol Cold
– Market share: 7%
– Tylenol Cold is a popular choice for consumers seeking relief from cough and congestion.
7. NyQuil
– Market share: 6%
– NyQuil is a trusted brand that offers nighttime relief from cold and flu symptoms.
8. Chestal
– Market share: 5%
– Chestal is a natural cough syrup brand that has gained a following in the USA for its gentle yet effective formula.
9. Mucinex
– Market share: 4%
– Mucinex is known for its innovative products that target mucus and congestion, providing relief for consumers.
10. Zarbee’s Naturals
– Market share: 4%
– Zarbee’s Naturals is a popular choice for consumers seeking natural remedies for cough and cold symptoms.
Insights:
The market for mentholated salve and cough balm in the USA is expected to continue growing in the coming years, driven by increasing consumer demand for natural and effective remedies for cold and flu symptoms. According to industry forecasts, the market is projected to reach a value of $600 million by 2025, with a compound annual growth rate of 5%. Brands that focus on natural ingredients and innovative formulations are likely to see the most success in this competitive market. Additionally, with the ongoing COVID-19 pandemic, there is a growing emphasis on products that provide relief from respiratory symptoms, further driving the demand for mentholated salve and cough balm in the USA.
Related Analysis: View Previous Industry Report
